Here is the latest stock price and chart of Religare Enterprises. For more details, see the Religare Enterprises company fact sheet and quarterly results. For a sector overview, read our finance sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
Get Details: We are Bullish on These 3 Little-known Stocks
Live BSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)64.05 | Open (Rs) 65.05 | High (Rs) 65.55 | Low (Rs) 63.55 |
% Change-1.54 | Volume 24,216 | Value (Rs) 1,559,331 | 52-Week H/L 75.85 / 17.20 |
Live NSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)64.05 | Open (Rs) 64.30 | High (Rs) 65.45 | Low (Rs) 63.55 |
% Change-1.69 | Volume 158,111 | Value (Rs) 10,127,010 | 52-Week H/L 76.00 / 17.15 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.54% | 1 Month -4.12% | 3 Months 19.16% | 1 Year 37.59% | 5 Years (CAGR)* -26.96% | 10 Years (CAGR)* -18.16% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* -7.64 | P/E Ratio (x) NM | Market Cap (Rs m) 11,422.04 | P/BV (x) 0.68 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
RELIGARE ENT last traded price was down 1.5% to Rs 64.1 on the BSE. On the NSE, RELIGARE ENT last traded price was down 1.7% to Rs 64.1. The total volume of shares traded was 0.2 m.
Overall, the benchmark S&P BSE SENSEX was at 48,878.5 (down 1.5%).
Over the last 30 days, the RELIGARE ENT share price is down 1.5%. And over the last one year, RELIGARE ENT share price is up 34.6%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.
Monopolistic railway financer with impeccable asset quality.
Does the company having 70% market share of the mutual fund registrar business have sound prospects?
For the quarter ended December 2018, RELIGARE ENT. has posted a net profit of Rs 103 m (up 75.2% YoY). Sales on the other hand came in at Rs 8 m (down 90.1% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More